A detailed history of Raymond James Trust N.A. transactions in Pfizer Inc stock. As of the latest transaction made, Raymond James Trust N.A. holds 458,248 shares of PFE stock, worth $12.3 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
458,248
Previous 441,421 3.81%
Holding current value
$12.3 Million
Previous $12.4 Million 7.38%
% of portfolio
0.29%
Previous 0.29%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $466,107 - $528,199
16,827 Added 3.81%
458,248 $13.3 Million
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $732 - $858
-29 Reduced 0.01%
441,421 $12.4 Million
Q1 2024

Apr 24, 2024

SELL
$25.89 - $29.73 $2.22 Million - $2.55 Million
-85,852 Reduced 16.28%
441,450 $12.3 Million
Q4 2023

Jan 10, 2024

BUY
$26.13 - $33.94 $297,202 - $386,033
11,374 Added 2.2%
527,302 $15.2 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $22,270 - $26,031
-694 Reduced 0.13%
515,928 $17.1 Million
Q2 2023

Aug 15, 2023

BUY
$36.12 - $41.79 $546,712 - $632,533
15,136 Added 3.02%
516,622 $18.9 Million
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $95,166 - $123,892
2,416 Added 0.48%
501,486 $20.5 Million
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $614,560 - $802,240
14,720 Added 3.04%
499,070 $25.6 Million
Q3 2022

Oct 31, 2022

BUY
$43.76 - $53.42 $511,948 - $624,960
11,699 Added 2.48%
484,350 $21.2 Million
Q2 2022

Jul 14, 2022

SELL
$46.53 - $55.17 $746,201 - $884,761
-16,037 Reduced 3.28%
472,651 $24.8 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $429,775 - $532,545
9,394 Added 1.96%
488,688 $25.3 Million
Q4 2021

Jan 31, 2022

SELL
$41.32 - $61.25 $1.01 Million - $1.5 Million
-24,520 Reduced 4.87%
479,294 $28.3 Million
Q3 2021

Oct 18, 2021

SELL
$39.25 - $50.42 $290,960 - $373,763
-7,413 Reduced 1.45%
503,814 $21.7 Million
Q2 2021

Jul 20, 2021

SELL
$35.91 - $40.68 $426,969 - $483,685
-11,890 Reduced 2.27%
511,227 $20 Million
Q1 2021

May 03, 2021

SELL
$33.49 - $37.77 $551,077 - $621,505
-16,455 Reduced 3.05%
523,117 $19 Million
Q4 2020

Jan 13, 2021

SELL
$33.47 - $42.56 $1.17 Million - $1.48 Million
-34,812 Reduced 6.06%
539,572 $19.9 Million
Q3 2020

Oct 14, 2020

SELL
$31.75 - $37.25 $491,871 - $577,077
-15,492 Reduced 2.63%
574,384 $21.1 Million
Q2 2020

Jul 16, 2020

BUY
$30.12 - $36.54 $28,192 - $34,201
936 Added 0.16%
589,876 $19.3 Million
Q1 2020

Apr 17, 2020

SELL
$27.03 - $38.62 $22,543 - $32,209
-834 Reduced 0.14%
588,940 $19.2 Million
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $915,669 - $1.04 Million
27,815 Added 4.95%
589,774 $23.1 Million
Q3 2019

Oct 24, 2019

BUY
$32.49 - $42.13 $2.16 Million - $2.8 Million
66,484 Added 13.42%
561,959 $20.2 Million
Q2 2019

Jul 15, 2019

BUY
$36.98 - $41.52 $224,949 - $252,566
6,083 Added 1.24%
495,475 $21.5 Million
Q1 2019

Apr 15, 2019

SELL
$37.5 - $41.2 $503,287 - $552,945
-13,421 Reduced 2.67%
489,392 $20.8 Million
Q4 2018

Jan 29, 2019

SELL
$38.47 - $43.86 $1.36 Million - $1.55 Million
-35,328 Reduced 6.56%
502,813 $21.9 Million
Q3 2018

Oct 16, 2018

SELL
$34.47 - $41.81 $204,717 - $248,309
-5,939 Reduced 1.09%
538,141 $23.7 Million
Q2 2018

Nov 26, 2018

BUY
$32.98 - $35.16 $188,513 - $200,974
5,716 Added 1.06%
544,080 $19.7 Million
Q2 2018

Jul 11, 2018

BUY
$32.98 - $35.16 $690,766 - $736,426
20,945 Added 4.05%
538,364 $19.5 Million
Q1 2018

Apr 05, 2018

BUY
$31.91 - $37.02 $97,357 - $112,948
3,051 Added 0.59%
517,419 $18.4 Million
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $201,422 - $213,716
6,056 Added 1.19%
514,368 $18.6 Million
Q3 2017

Oct 24, 2017

BUY
$31.0 - $34.15 $606,050 - $667,632
19,550 Added 4.0%
508,312 $18.1 Million
Q2 2017

Aug 10, 2017

BUY
N/A
488,762
488,762 $16.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.